288 related articles for article (PubMed ID: 21221974)
1. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.
Berges R; Oelke M
World J Urol; 2011 Apr; 29(2):171-8. PubMed ID: 21221974
[TBL] [Abstract][Full Text] [Related]
2. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
3. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample.
Berges R; Gsur A; Feik E; Höfner K; Senge T; Pientka L; Baierl A; Michel MC; Ponholzer A; Madersbacher S
World J Urol; 2011 Apr; 29(2):143-8. PubMed ID: 19921206
[TBL] [Abstract][Full Text] [Related]
5. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
Lee JH; Kim Y; Park YW; Lee DG
J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
[TBL] [Abstract][Full Text] [Related]
6. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
Fukuta F; Masumori N; Mori M; Tsukamoto T
BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
[TBL] [Abstract][Full Text] [Related]
8. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
[TBL] [Abstract][Full Text] [Related]
9. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
Tsukamoto T; Masumori N; Rahman M; Crane MM
Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
[TBL] [Abstract][Full Text] [Related]
10. Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia.
Sciarra A; D'Eramo G; Casale P; Loreto A; Buscarini M; Di Nicola S; Seccareccia F; Di Silverio F
Prostate; 1998 Feb; 34(2):121-8; discussion 129. PubMed ID: 9465943
[TBL] [Abstract][Full Text] [Related]
11. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.
Park YW; Kim SB; Kwon H; Kang HC; Cho K; Lee KI; Kim YJ; Lee JH
Urology; 2013 Sep; 82(3):674-9. PubMed ID: 23850334
[TBL] [Abstract][Full Text] [Related]
12. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
Jhang JF; Jiang YH; Kuo HC
Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
[TBL] [Abstract][Full Text] [Related]
13. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
14. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
[TBL] [Abstract][Full Text] [Related]
15. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology.
Schatzl G; Brössner C; Schmid S; Kugler W; Roehrich M; Treu T; Szalay A; Djavan B; Schmidbauer CP; Söregi S; Madersbacher S
Urology; 2000 Mar; 55(3):397-402. PubMed ID: 10699620
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive patient evaluation for benign prostatic hyperplasia.
Jepsen JV; Bruskewitz RC
Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
[TBL] [Abstract][Full Text] [Related]
18. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
[TBL] [Abstract][Full Text] [Related]
19. Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment.
Roehrborn CG; Kaminetsky JC; Auerbach SM; Montelongo RM; Elion-Mboussa A; Viktrup L
BJU Int; 2010 Feb; 105(4):502-7. PubMed ID: 19732051
[TBL] [Abstract][Full Text] [Related]
20. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
